Abstract The Argus® II Retinal Prosthesis System (Second Sight Medical Products) is the
first prosthetic vision device to obtain regulatory approval in both Europe and the USA. As …

Retinal prostheses are designed to restore a basic sense of sight to people with profound
vision loss. They require a relatively intact posterior visual pathway (optic nerve, lateral …

Electronic visual prostheses, or biomimetic eyes, have shown the feasibility of restoring
functional vision in the blind through electrical pulses to initiate neural responses artificially …

Over the last decade, in pursuit to provide suitable alternatives for power supplies of medical
devices in regenerative medicine, extensive research on nanogenerators has been …

Retinal prosthesis systems have undergone significant advances in the past quarter century,
resulting in the development of several different novel surgical and engineering approaches …

Retinal degeneration, a leading cause of blindness worldwide, is primarily characterized by
the dysfunctional/degenerated photoreceptors that impair the ability of the retina to detect …

Retinal prostheses have been developed to fight blindness in people affected by outer
retinal layer dystrophies. To date, few hundred patients have received a retinal implant …

Alain Berthoz présente dans ce nouveau livre un concept clé, la «vicariance». Lorsqu'un de
nos sens en remplace un autre qui fait défaut (lorsque nous tâtonnons dans le noir, ou …

Retinal prosthesis has been translated from the laboratory to the clinic over the past two
decades. Currently, two devices have regulatory approval for the treatment of retinitis …

Degenerative retinal diseases such as retinitis pigmentosa and macular degeneration cause
irreversible vision loss in more than 10 million people worldwide. Retinal prostheses, now …